← back to search

Güray Saydam

Izmir University · TR
Area of research
Genetics · Hematology
Research interest
Research interests include Chronic Myeloid Leukemia Treatments, Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, and Myeloproliferative Neoplasms: Diagnosis and Treatment.
h-index
26
citations
2,601
works
410
NIH funding
—
primary concept
Medicine
email
guray.saydam@ege.edu.tr

Recent publications

Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study
Blood 2025cited by 37position: middledoi
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial
The Lancet Oncology 2021cited by 135position: middledoi
Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial
Annals of Hematology 2018cited by 60position: middledoi
Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study
The Lancet Oncology 2016cited by 251position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Timothy Devos · KU Leuven2 papers (2016–2018)Jeannie Callum · Manchester University NHS Foundation Trust2 papers (2016–2018)Francesca Palandri · Bristol-Myers Squibb (Switzerland)2 papers (2016–2018)Martin Grießhammer · Johannes Wesling Klinikum Minden2 papers (2016–2018)Francesco Passamonti · University of Insubria2 papers (2016–2018)— · 2 papers (2016–2018)Md Mahmudul Hasan Khan · Iowa State University2 papers (2016–2018)Giulia Benevolo · Azienda Ospedaliera Citta' della Salute e della Scienza di Torino2 papers (2016–2018)Miklós Egyed · University Hospital Hradec Králové2 papers (2016–2018)— · 2 papers (2016–2018)Paola Guglielmelli · Assiut University1 papers (2018–2018)Julian Perez-Ronco · Novartis (Switzerland)1 papers (2018–2018)Alessandro M. Vannucchi · All India Institute of Medical Sciences1 papers (2016–2016)— · 1 papers (2016–2016)